16:02 Dec 20
Abbott India Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Abbott India Ltd.
77/100 High Financial Strength
Quality20/100 Expensive Valuation
Valuation63/100 Technically Moderately Bullish
TechnicalSWOT
Strength
13
Weakness
3
Opportunity
1
Threat
0
60.89K
Market Cap (Cr)
47.40
PE Ratio
17.29
Price to Book Ratio
52.92
RSI
0.00 %
Net Profit Margin
Rating Based on 3 Analysts
Buy
100%
Hold
0%
Sell
0%
Buy
Analyst Price Target
The average price target is 31973.33 with a high estimate of 32500 and low estimate of 31420
Current 28655.35
Disclaimer:The analysis information is for reference only and does not constitude an investment recommendation
SWOT
Download Our App On:
